Moxifloxacine Eg

Moxifloxacin, the active ingredient in Moxifloxacine Eg, is a fluoroquinolone presented as a tablet for oral use. It treats a range of bacterial infections in adults, including pneumonia, sinusitis and bronchitis. GNH USA supplies Moxifloxacine Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moxifloxacine Eg is a fluoroquinolone antibacterial used to treat several serious bacterial infections. - Community‑acquired bacterial pneumonia: eradicates the causative pathogens and improves respiratory function. - Acute bacterial sinusitis: reduces sinus inflammation and clears infection. - Acute bacterial exacerbation of chronic bronchitis: shortens symptom duration and prevents complications. - Skin and skin structure infections: eliminates skin‑resident bacteria and promotes healing. - Intra‑abdominal infections: targets mixed bacterial flora to resolve intra‑abdominal sepsis.

Moxifloxacine Eg may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, sometimes watery. - Headache: transient cranial discomfort. - Dizziness: sensation of light‑headedness. - Rash: skin redness or itching. - Photosensitivity: increased skin reaction to sunlight.

Serious or Rare Side Effects: - Tendon rupture: sudden tendon pain or swelling, especially in the Achilles. - QT interval prolongation: risk of cardiac arrhythmias. - Severe allergic reactions: anaphylaxis, angioedema, or Stevens‑Johnson syndrome. - Clostridioides difficile infection: severe colitis with watery diarrhea. - Hepatotoxicity: elevated liver enzymes or jaundice. - Peripheral neuropathy: numbness or tingling in extremities.

Before prescribing Moxifloxacine Eg, clinicians should consider several safety measures. - Assess renal function: adjust therapy if renal impairment is present. - Monitor for tendon pain: discontinue if signs of tendonitis or rupture appear. - Check QT interval: avoid in patients with known prolonged QT or electrolyte disturbances. - Avoid use in pregnancy Category C unless benefits outweigh risks. - Avoid concomitant use with other QT‑prolonging agents. - Store at below 25°C: keep in the original pack, protect from moisture.

Moxifloxacine Eg can interact with several medicines, requiring careful management.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce drug absorption. - Warfarin: increase anticoagulant effect and bleeding risk. - Theophylline: elevate serum theophylline concentrations.

Moderate Interactions (Monitor Closely): - Ciprofloxacin: additive QT‑prolongation effect. - NSAIDs: heightened risk of central nervous system adverse events. - Oral contraceptives: possible reduction in contraceptive efficacy.